Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Green tea extract protects against hepatic NFκB activation along the gut-liver axis in diet-induced obese mice with nonalcoholic steatohepatitis by reducing endotoxin and TLR4/MyD88 signaling
Jinhui Li, Geoffrey Y. Sasaki, Priyankar Dey, et al.
The Journal of Nutritional Biochemistry (2017) Vol. 53, pp. 58-65
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Anti-Inflammatory, Antioxidant, and Neuroprotective Effects of Polyphenols—Polyphenols as an Element of Diet Therapy in Depressive Disorders
Anna Winiarska‐Mieczan, Małgorzata Kwiecień, Karolina Jachimowicz-Rogowska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2258-2258
Open Access | Times Cited: 51
Green tea extract prevents obesity in male mice by alleviating gut dysbiosis in association with improved intestinal barrier function that limits endotoxin translocation and adipose inflammation
Priyankar Dey, Geoffrey Y. Sasaki, Ping Wei, et al.
The Journal of Nutritional Biochemistry (2019) Vol. 67, pp. 78-89
Open Access | Times Cited: 125
Mechanisms Underlying the Anti-Depressive Effects of Regular Tea Consumption
Dylan O’Neill Rothenberg, Lingyun Zhang
Nutrients (2019) Vol. 11, Iss. 6, pp. 1361-1361
Open Access | Times Cited: 125
Molecular mechanisms underlying health benefits of tea compounds
Ao Shang, Jiahui Li, Dan-Dan Zhou, et al.
Free Radical Biology and Medicine (2021) Vol. 172, pp. 181-200
Closed Access | Times Cited: 102
Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE−/− mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammation
Dan Feng, Jun Zou, Dongfang Su, et al.
Nutrition & Metabolism (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 86
Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism
Guoyi Tang, Yu Xu, Cheng Zhang, et al.
Antioxidants (2021) Vol. 10, Iss. 7, pp. 1076-1076
Open Access | Times Cited: 86
Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiota
Priyankar Dey, Bryan D. Olmstead, Geoffrey Y. Sasaki, et al.
The Journal of Nutritional Biochemistry (2020) Vol. 84, pp. 108455-108455
Open Access | Times Cited: 72
Bioactive compounds modulating Toll-like 4 receptor (TLR4)-mediated inflammation: pathways involved and future perspectives
Karen Salve Coutinho‐Wolino, Patrícia Pereira Almeida, Denise Mafra, et al.
Nutrition Research (2022) Vol. 107, pp. 96-116
Open Access | Times Cited: 51
Quercetin improves high‐fat diet‐induced obesity by modulating gut microbiota and metabolites in C57BL/6J mice
Lijie Su, Yupeng Zeng, Guokun Li, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 12, pp. 4558-4572
Closed Access | Times Cited: 40
The relationship between vitamin C status, the gut-liver axis, and metabolic syndrome
Maret G. Traber, Garry R. Buettner, Richard S. Bruno
Redox Biology (2018) Vol. 21, pp. 101091-101091
Open Access | Times Cited: 73
Preventive Efficiency of Green Tea and Its Components on Nonalcoholic Fatty Liver Disease
Jie Zhou, Chi‐Tang Ho, Piaopiao Long, et al.
Journal of Agricultural and Food Chemistry (2019) Vol. 67, Iss. 19, pp. 5306-5317
Closed Access | Times Cited: 69
Anti-inflammatory activities of green tea catechins along the gut–liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studies
Joanna K. Hodges, Geoffrey Y. Sasaki, Richard S. Bruno
The Journal of Nutritional Biochemistry (2020) Vol. 85, pp. 108478-108478
Closed Access | Times Cited: 61
Targeting gut barrier dysfunction with phytotherapies: Effective strategy against chronic diseases
Priyankar Dey
Pharmacological Research (2020) Vol. 161, pp. 105135-105135
Closed Access | Times Cited: 54
Arabinoxylan from rice bran protects mice against high-fat diet-induced obesity and metabolic inflammation by modulating gut microbiota and short-chain fatty acids
Shunjing Luo, He Li, Huibin Zhang, et al.
Food & Function (2022) Vol. 13, Iss. 14, pp. 7707-7719
Closed Access | Times Cited: 29
Sulforaphane Ameliorates Nonalcoholic Fatty Liver Disease Induced by High-Fat and High-Fructose Diet via LPS/TLR4 in the Gut–Liver Axis
Ye Xu, Xianghui Huang, Bingxin Huangfu, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 743-743
Open Access | Times Cited: 20
A combination of Pueraria lobata and Silybum marianum protects against alcoholic liver disease in mice
Ruibing Feng, Jie‐Hua Chen, Conghui Liu, et al.
Phytomedicine (2019) Vol. 58, pp. 152824-152824
Closed Access | Times Cited: 45
Cancer-Associated Microbiota: From Mechanisms of Disease Causation to Microbiota-Centric Anti-Cancer Approaches
Priyankar Dey, Saumya Ray Chaudhuri
Biology (2022) Vol. 11, Iss. 5, pp. 757-757
Open Access | Times Cited: 25
The effect of Epigallocatechin‐3‐gallate on small intestinal morphology, antioxidant capacity and anti‐inflammatory effect in heat‐stressed broilers
Jiao Song, Xin Lei, Jingxian Luo, et al.
Journal of Animal Physiology and Animal Nutrition (2019) Vol. 103, Iss. 4, pp. 1030-1038
Closed Access | Times Cited: 42
Design of Hepatic Targeted Drug Delivery Systems for Natural Products: Insights into Nomenclature Revision of Nonalcoholic Fatty Liver Disease
Rou Tang, Rui Li, He Li, et al.
ACS Nano (2021) Vol. 15, Iss. 11, pp. 17016-17046
Closed Access | Times Cited: 29
EGCG and catechin relative to green tea extract differentially modulate the gut microbial metabolome and liver metabolome to prevent obesity in mice fed a high-fat diet
Xiaowei Sun, Priyankar Dey, Richard S. Bruno, et al.
The Journal of Nutritional Biochemistry (2022) Vol. 109, pp. 109094-109094
Open Access | Times Cited: 20
The Pathogenesis of HCC Driven by NASH and the Preventive and Therapeutic Effects of Natural Products
Gaoxuan Shao, Ying Liu, Lu Lu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
The intestinal-level metabolic benefits of green tea catechins: Mechanistic insights from pre-clinical and clinical studies
Dwinder Sidhu, M. Vasundhara, Priyankar Dey
Phytomedicine (2023) Vol. 123, pp. 155207-155207
Closed Access | Times Cited: 12
Preventive and therapeutic effects of natural products and herbal extracts on nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Yiming Cao, Xiaoxue Fang, Mingyang Sun, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 9, pp. 3867-3897
Open Access | Times Cited: 11
A green tea extract confection decreases circulating endotoxin and fasting glucose by improving gut barrier function but without affecting systemic inflammation: A double-blind, placebo-controlled randomized trial in healthy adults and adults with metabolic syndrome
Min Zeng, Joanna K. Hodges, Avinash Pokala, et al.
Nutrition Research (2024) Vol. 124, pp. 94-110
Open Access | Times Cited: 4
A review on the effects of flavan-3-ols, their metabolites, and their dietary sources on gut barrier integrity
Sara Dobani, L. Kirsty Pourshahidi, Nigel G. Ternan, et al.
Food & Function (2025)
Closed Access
Page 1 - Next Page

Scroll to top